The Patent Finder

Envoy Therapeutics, Inc.

Also on record
Records under this name other than patents Envoy Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Envoy Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,670,2295-HT3 Receptor Antagonists
In force
 · Medium confidence
In forceMedium confidence
US 10,125,1455-HT3 Receptor Antagonists
In force
 · Medium confidence
In forceMedium confidence
US 10,407,4435-HT3 Receptor Antagonists
In force
 · Medium confidence
In forceMedium confidence
US 9,012,4475-HT3 Receptor Antagonists
In force
 · High confidence
In forceHigh confidence
US 9,487,526Quinoxaline Derivatives as GPR6 Modulators
In force
 · High confidence
In forceHigh confidence
US 9,770,452Quinoxaline Derivatives as GPR6 Modulators
In force
 · High confidence
In forceHigh confidence
US 9,181,249SUBSTITUTED PYRIDO[3,4-b]PYRAZINES AS GPR6 MODULATORS
In force
 · High confidence
In forceHigh confidence
US 10,077,266SUBSTITUTED PYRIDO[3,4-b]PYRAZINES AS GPR6 MODULATORS
In force
 · Low confidence
In forceLow confidence
US 10,738,046Substituted Pyrido[3,4-b]pyrazines as GPR6 Modulators
In force
 · Low confidence
In forceLow confidence
US 9,708,313SUBSTITUTED PYRIDO[3,4-b]PYRAZINES AS GPR6 MODULATORS
In force
 · Medium confidence
In forceMedium confidence
10 of 19 records shown.
Pro members see all 19.
Pro members: see all 19 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited